GlobeNewswire
Aquestive Therapeutics to Present New Clinical Data on Anaphylm™ (dibutepinephrine) Sublingual Film at the 2026 AAAAI Annual Meeting
📈
AI Sentiment
Highly Positive
8/10
Aquestive Therapeutics Inc. News
Latest updates and market news for AQST
2 news
Feb 15 - Feb 21, 2026
Page 1
GlobeNewswire
Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer
📈
AI Sentiment
Highly Positive
8/10
Share this news page